University of Iowa Pharmaceuticals

University of Iowa Pharmaceuticals (UI Pharmaceuticals) is a pharmaceutical manufacturing facility based in Iowa City, Iowa. As the largest university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States, UI Pharmaceuticals boasts nearly 45 years of experience in developing formulations, manufacturing products, and conducting analytical testing in accordance with current Good Manufacturing Practices (cGMPs). UI Pharmaceuticals offers a comprehensive range of pharmaceutical dosage forms, including sterile injectable solutions, sterile lyophilized (freeze-dried) powders, topical and oral solutions, emulsions, and suspensions, tablets (uncoated and film or functional coated), and hard gelatin capsules (powder or hot melt filled). Their clientele spans a wide spectrum, encompassing pharmaceutical and biotechnology companies of all sizes, both domestically and internationally. The company has also collaborated with numerous government agencies, including the National Cancer Institute, the Centers for Disease Control, and the National Institutes of Health. UI Pharmaceuticals distinguishes itself through its extensive experience, comprehensive capabilities, and commitment to regulatory compliance. The facility is compliant with 21 CFR parts 11, 210, and 211, holds a Drug Enforcement Agency (DEA) license to handle controlled substances (Schedules I - V), and is equipped to handle potent/cytotoxic materials. Furthermore, UI Pharmaceuticals has successfully produced products for the European Union (EU) and passed multiple Qualified Person (QP) audits. For inquiries or to discuss your pharmaceutical manufacturing needs, please visit their website at uip.pharmacy.uiowa.edu.